Multiple Myeloma Hub (@mm_hub) 's Twitter Profile
Multiple Myeloma Hub

@mm_hub

An online educational resource run in collaboration with the European School of Haematology @ESHaematology linktr.ee/MultipleMyelom… #mmsm #myeloma

ID: 857866557778743296

linkhttp://www.multiplemyelomahub.com calendar_today28-04-2017 07:58:20

6,6K Tweet

9,9K Takipçi

2,2K Takip Edilen

Multiple Myeloma Hub (@mm_hub) 's Twitter Profile Photo

CONGRESS | #EHA2025 | POSTER Fredrik Schjesvold, Fredrik Schjesvold, OsloMyelomaCenter presents updated results from the phase 1/2 CA057-003 trial of mezigdomide (MEZId) in RRMM (N=56). No new safety signals were identified across all cohorts. ORR - MEZId+TAM: 50%; MEZId+BMS-986158: 35%;

CONGRESS | #EHA2025 | POSTER
Fredrik Schjesvold, <a href="/MyelomaOslo/">Fredrik Schjesvold</a>, <a href="/CenterOslo/">OsloMyelomaCenter</a> presents updated results from the phase 1/2 CA057-003 trial of mezigdomide (MEZId) in RRMM (N=56).
No new safety signals were identified across all cohorts. 
ORR - MEZId+TAM: 50%; MEZId+BMS-986158: 35%;